
Breakthrough Trial Targets Untreatable Cancers with PMR-116
Australian researchers launch a pioneering trial using PMR-116 to tackle MYC-driven cancers, redefining precision oncology and offering fresh hope.
News That Embraces Insight and Understanding
Australian researchers launch a pioneering trial using PMR-116 to tackle MYC-driven cancers, redefining precision oncology and offering fresh hope.
Former U.S. President Biden has been diagnosed with an aggressive, hormone-sensitive prostate cancer. Here are the key details.
Israeli researchers reveal how cancer dormancy might unlock new treatments to prevent relapse.
Experts urge men 50+ to get regular PSA screenings amid rising prostate cancer rates. Early detection is key for better outcomes.
China’s new anti-cancer guide offers practical lifestyle tips—balanced diet, exercise, and more—for a healthier future.
Breakthrough study uncovers how breast cancer cells hijack arginine to reprogram immune cells, paving the way for precision therapies.
Chinese scientists uncover how natural compound silybin blocks lactate transport, offering fresh hope in the fight against liver cancer.